Research
Micronutrients & recovery
Vitamin E improves steatohepatitis in nondiabetic patients but is not recommended for diabetic patients due to cardiovascular risks.
If you have fatty liver but do not have diabetes, Vitamin E supplementation may improve your liver inflammation. However, if you have diabetes, do not take Vitamin E for this purpose, as it may increase your risk of heart problems. Consult your doctor to determine if this is appropriate for your specific health profile.
GoodQualifiesHIGH confidence
Vitamin E is a potent antioxidant. It is well tolerated, improves serum aminotransferase levels, reduces hepatic steatosis, and in nondiabetics, improves steatohepatitis but not fibrosis [76, 77]. Due to cardiovascular risks in diabetic patients, vitamin E is not recommended in diabetic patients with NAFLD [78].
Why this rating
Based on cited studies [76, 77, 78] showing benefit in nondiabetics and risk in diabetics.
Source
NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
Marinko Marušić et al. · Canadian Journal of Gastroenterology and Hepatology · 2021
narrative_reviewCited 206×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →